Corindus vascular robotics, inc. (CVRS)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Mar'14Dec'13Mar'13Mar'12
Operating activities
Net loss

-34,989

-34,123

-33,078

-28,763

-24,541

-267

-14,691

-189

-51

Adjustments to reconcile net loss to net cash flows used in operating activities:
Loss on disposal of fixed assets

-

-

-81

-

-

-

-

-

-

Impairment of property and equipment

-

-

125

-

-

-

-

-

-

Depreciation and amortization

853

723

725

706

622

-

607

-

-

Stock-based compensation expense

3,235

2,892

2,366

505

377

-

329

-

-

Accretion of interest expense

328

101

422

625

106

-

0

-

-

Write down of inventories

268

268

-

-

341

-

0

-

-

Accretion of available-for-sale securities

-

-

15

13

-

-

0

-

-

Warrant liability revaluation

-120

-

-

-

2,421

-

171

-

-

Loss on disposal of property and equipment

-62

-28

-

-

-

-

-

-

-

Amortization of website development costs

-

-

-

-

-

8

-

8

5

In-kind compensation

-

-

-

-

-

10

-

10

9

Changes in operating assets and liabilities:
Accounts receivable

1,736

2,479

-494

404

438

39

23

-24

-15

Due from related party

-

-250

250

-

-125

-

-130

-

-

Prepaid expenses and other current assets

-130

91

-143

17

80

-

-134

-

-

Deferred inventory costs

-

-

-

102

-102

-

0

-

-

Inventories

1,026

1,638

216

346

-257

-

2,313

-

-

Deposits and other assets

-18

1

-7

-56

-24

-

-89

-

-

Accounts payable, accrued expenses and other liabilities

689

1,817

1,530

-380

1,584

-

329

-

-

Customer deposits

-93

93

-

-

-

-

-

-

-

Deferred revenue

347

-198

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

0

-

-0

-

Security deposit

-

-

-

-

-

0

-

0

-0

Bank overdraft

-

-

-

-

-

-3

-

3

-

Increase (decrease) in bank overdraft

-

-

-

-

-

-

-

-

0

Accounts payable

-

-

-

-

-

-3

-

1

1

Accrued expenses and other liabilities

-

-

-

-

-

118

-

98

18

Deferred revenue

-

-

72

73

733

-

-65

-

-

Net cash used in operating activities

-32,034

-32,358

-27,594

-27,856

-

-96

-

-92

-31

Investing activities
Purchase of property and equipment

736

245

531

268

122

-

378

-

-

Net cash used in operating activities

-

-

-

-

-18,571

-

-15,303

-

-

Purchases of available-for-sale securities

-

-

-

22,766

-

-

0

-

-

Maturities of available-for-sale securities

-

-

20,553

2,241

-

-

0

-

-

Collection of notes receivable

-

71

65

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-122

-

-378

-

-

Website development costs

-

-

-

-

-

0

-

0

26

Net cash used in investing activities

-736

-174

20,087

-20,793

-

0

-

0

-26

Financing activities
Proceeds from issuance of common stock, net of issuance costs

2,818

44,611

-

44,392

27,487

0

-10

0

107

Proceeds from issuance of long term debt and warrants, net of deferred financing costs and discounts

11,626

-

-

-50

9,890

-

0

-

-

Proceeds from issuance of Series A preferred stock and warrants, net of issuance costs

24,671

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

108

65

72

76

-

-

0

-

-

Payments for withholding taxes on stock option exercises

13

-

-

-

-

-

-

-

-

Payments on debt

-

-3,856

-4,373

-2,022

-

-

-

-

-

Payment for common stock repurchase and retirement

-

-

741

-

-

-

-

-

-

Payments for withholding taxes on stock option exercises

-

-

410

131

-

-

-

-

-

Payments on capital lease obligation

49

13

-

-

-

-

-

-

-

Payments on long term debt

-

-

-

-

-

-

0

-

-

Other

-

-

-

-

-3

-

0

-

-

Net cash provided by (used in) financing activities

-

-

-

-

37,374

-

-10

-

-

Proceeds from notes payable

-

-

-

-

-

3

-

46

-

Proceeds from loans and advances from related party

-

-

-

-

-

106

-

0

10

Repayments to notes payable

-

-

-

-

-

0

-

2

-

Repayments to notes payable-related party

-

-

-

-

-

13

-

0

10

Net cash provided by financing activities

39,161

40,807

-5,452

42,265

-

96

-

43

107

Net increase in cash and cash equivalents

6,391

8,275

-12,959

-6,384

18,681

0

-15,691

-48

48

Supplemental Disclosure of Cash Flow Information:
Accrued dividends on Series A preferred stock

628

-

-

-

-

-

-

-

-

Fair value of warrants issued with long-term debt

210

-

-

-

-

-

-

-

-

Interest paid

878

157

652

976

-

-

-

-

-

Financing costs included in accounts payable and accrued expenses

130

-

-

-

-

-

-

-

-

Reclassification of warrant liability to stockholders' equity

-

-

-

-

5,803

-

-

-

-

Issuance of Series A-1 preferred stock as dividends on Series A preferred stock

1,760

-

-

-

-

-

-

-

-

Deferred public offering costs in accounts payable and accrued expenses

-

-

-

-

50

-

-

-

-

Interest paid

-

-

-

-

266

0

-

1

0

Transfer from inventories to property and equipment in the field

425

812

-

587

347

-

588

-

-

Fair value of warrants issued with Series A preferred stock

4,162

-

-

-

-

-

-

-

-

Assets acquired under capital lease

-

164

-

-

-

-

-

-

-

Income tax paid

-

-

-

-

-

0

-

0

0